Search Page

1

Cite

Share

Usefulness of home BP determination in treating borderline hypertension.

Cottier C, Julius S, Gajendragadkar SV, Schork MA. Cottier C, et al. Among authors: julius s. JAMA. 1982 Aug 6;248(5):555-8. JAMA. 1982. PMID: 7047770 Clinical Trial.

Cite

Share

2

Cite

Share

Practical management of borderline hypertension.

Julius S. Julius S. Compr Ther. 1980 Mar;6(3):43-8. Compr Ther. 1980. PMID: 7363582

Cite

Share

3

Cite

Share

Use of clonidine and propranolol as monotherapy in borderline hypertension.

Cottier C, Julius S. Cottier C, et al. Among authors: julius s. Chest. 1983 Feb;83(2 Suppl):422-5. doi: 10.1378/chest.83.2_supplement.422. Chest. 1983. PMID: 6337032 Clinical Trial.

Cite

Share

4

Cite

Share

Borderline hypertension.

Egan B, Julius S. Egan B, et al. Among authors: julius s. Prim Care. 1983 Mar;10(1):99-113. Prim Care. 1983. PMID: 6348822

Cite

Share

5

Cite

Share

Practical utility of blood pressure readings obtained by self-determination.

Mejia A, Julius S. Mejia A, et al. Among authors: julius s. J Hypertens Suppl. 1989 May;7(3):S53-7. J Hypertens Suppl. 1989. PMID: 2668465 Clinical Trial.

Cite

Share

6

Cite

Share

The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure study.

Julius S, Jamerson K, Mejia A, Krause L, Schork N, Jones K. Julius S, et al. JAMA. 1990 Jul 18;264(3):354-8. JAMA. 1990. PMID: 2362331

Cite

Share

7

Cite

Share

"White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan.

Julius S, Mejia A, Jones K, Krause L, Schork N, van de Ven C, Johnson E, Petrin J, Sekkarie MA, Kjeldsen SE, et al. Julius S, et al. Hypertension. 1990 Dec;16(6):617-23. doi: 10.1161/01.hyp.16.6.617. Hypertension. 1990. PMID: 2246029

Cite

Share

8

Cite

Share

Home blood pressure monitoring: advantages and limitations.

Julius S. Julius S. J Hypertens Suppl. 1991 Dec;9(3):S41-6. J Hypertens Suppl. 1991. PMID: 1797999 Clinical Trial.

Cite

Share

9

Cite

Share

Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.

Okin PM, Wachtell K, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Lindholm LH, Nieminen MS, Edelman JM, Hille DA, Dahlöf B. Okin PM, et al. Among authors: julius s. JAMA. 2006 Sep 13;296(10):1242-8. doi: 10.1001/jama.296.10.1242. JAMA. 2006. PMID: 16968848 Clinical Trial.

Cite

Share

10

Cite

Share

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.

Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B; LIFE Study Investigators. Okin PM, et al. Among authors: julius s. JAMA. 2004 Nov 17;292(19):2343-9. doi: 10.1001/jama.292.19.2343. JAMA. 2004. PMID: 15547161 Clinical Trial.

Cite

Share